What heart rate defines an accelerated junctional rhythm?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Accelerated Junctional Rhythm Heart Rate

Accelerated junctional rhythm is defined by a heart rate of 70 to 130 bpm originating from the AV junction. 11

Heart Rate Definition

The 2015 ACC/AHA/HRS guidelines clearly distinguish accelerated junctional rhythm (also called nonparoxysmal junctional tachycardia) from paroxysmal junctional tachycardia based on rate:

  • Accelerated junctional rhythm: 70-130 bpm 11
  • Paroxysmal junctional tachycardia: 120-220 bpm 11

The key distinction is that accelerated junctional rhythm represents a slower junctional rate that exceeds the normal junctional escape rate (40-60 bpm) but remains below true tachycardia range.

Clinical Context

Accelerated junctional rhythm is far more common in adults than paroxysmal junctional tachycardia and has distinct clinical associations 11:

Common Etiologies:

  • Digoxin toxicity (most important to recognize)
  • Myocardial infarction
  • Post-cardiac surgery (particularly valve replacement, occurring in ~33% of valve patients vs 13% of CABG patients) 2
  • Acute myocarditis 3
  • Acute rheumatic fever 4

Mechanism:

The rhythm results from enhanced automaticity or triggered activity in the AV junction, not the reentrant mechanisms seen in other SVTs 11.

Important Clinical Pitfall

Some studies define accelerated junctional rhythm at rates >55 bpm 2, but the authoritative ACC/AHA/HRS guideline uses the 70-130 bpm range 11. The lower threshold of 70 bpm represents a rate that clearly exceeds the intrinsic junctional escape rate and indicates pathologic acceleration.

Management Approach

Treatment focuses on addressing the underlying condition rather than the rhythm itself 11. The rhythm may terminate with:

  • Beta blockers
  • Intravenous adenosine
  • Verapamil

However, identifying and treating the precipitating cause (especially digoxin toxicity or ischemia) takes priority over rhythm suppression.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.